The following is a summary of “Corticosteroids in Cardiogenic Shock: A Retrospective Analysis of the Medical Information Mart ...

For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.

Discover how heart centers across the country are improving patient outcomes and reducing mortality rates through innovative approaches and advanced therapies.

The following is a summary of “Patient Characteristics, Management and Long-term Outcomes of Patients with Cardiogenic Shock ...

The hypothesis and design of the SHOCK trial have been previously published. [9] Figure 1 outlines the trial design. The trial aimed to test the superiority of a strategy of early committed ...

Welcome to Washington’s new normal. President Trump promised shock and awe when he was elected, and his Inauguration Day at times felt like an effort to overwhelm his critics, his opponents and ...

A large randomized trial shows no difference in death rates with the two agents overall but significantly higher mortality with dopamine among patients with cardiogenic shock. When fluid therapy ...

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality. Despite advancements in emergency interventions, the optimal treatment ...

THE MEMO HAS CLEARLY GONE OUT: The phrase the incoming Trump administration is using to describe its opening days is “shock and awe.” Tom Homan, the incoming designated border czar, when asked during ...

Acute myocardial infarction-related cardiogenic shock (AMI-CS) is a severe, life-threatening condition characterised by inadequate tissue perfusion due to the heart’s inability to pump blood ...

Although mortality risk prediction in cardiogenic shock (CS) is possible ... Consecutive CS patients supported by pVAD Impella (Abiomed, Danvers, MA) at two national referral centers were included.